# Study of Subcutaneous Rehydration With Recombinant Human Hyaluronidase for Infants and Children

> **NCT00477152** · PHASE4 · COMPLETED · sponsor: **Baxter Healthcare Corporation** · enrollment: 52 (actual)

## Conditions studied

- Dehydration

## Interventions

- **DRUG:** hyaluronidase (human recombinant)/rehydration fluid

## Key facts

- **NCT ID:** NCT00477152
- **Lead sponsor:** Baxter Healthcare Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-08
- **Primary completion:** 2008-06
- **Final completion:** 2008-06
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2011-12-01

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00477152

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00477152, "Study of Subcutaneous Rehydration With Recombinant Human Hyaluronidase for Infants and Children". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00477152. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*